A Real-world Study to Assess the Use of Siponimod in Spain to Treat Patients With Secondary Progressive Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Understanding the 'Durable Effect' Concept of B-cell Modulating Therapies
- Status
- RECRUITING
- Phase
- N/A
Validation of Handheld Ultrasound Devices in Rheumatology
- Status
- COMPLETED
- Phase
- N/A
Relapse-Free Survival With Adjuvant Dabrafenib/Trametinib Therapy in Patients With BRAF V600-mutated Stage III/IV Melanoma
- Status
- COMPLETED
- Phase
- N/A
Low PSMA SUV Boost (LPS-Boost): Intensified 177Lu-PSMA-617 Treatment for Patients With Metastatic Castrate-Resistant Prostate Cancer With Low PSMA Expressing Disease
- Status
- RECRUITING
- Phase
- PHASE2
Study to Assess Changes in Immunoglobulins in Patients With Relapsing Multiple Sclerosis Treated With Anti-CD20 Therapies
- Status
- COMPLETED
- Phase
- N/A
Real-World Evaluation of Patient Characteristics and Treatment Patterns Among Patients With CML-CP Treated With Asciminib
- Status
- COMPLETED
- Phase
- N/A
A Real-world Study of Inclisiran Adherence, Treatment Patterns, Patient Characteristics, and Effectiveness in ASCVD Patients With Hypercholesterolemia, ASCVD-risk Equivalent Patients With Hypercholesterolemia and Familial Hypercholesterolemia
- Status
- COMPLETED
- Phase
- N/A
Standard of Care +/- 177Lu-PSMA-617 In de Novo mHSPC Patients With Poor PSA Response (PEACE6-Poor Responders)
- Status
- RECRUITING
- Phase
- PHASE3
Real-life Treatment Patterns With Cyclin-dependent Kinase Inhibitors in Advanced Breast Cancer in Portugal - REVEAL Study
- Status
- COMPLETED
- Phase
- N/A
Characteristics, Adherence, and Persistence Among Multiple Sclerosis Patients Treated With Disease-Modifying Therapies
- Status
- COMPLETED
- Phase
- N/A
Trametinib Plus Anlotinib Combined With Tislelizumab in KRAS-mutant NSCLC
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1/PHASE2
Peptide-coupled Red Blood Cells for the Treatment of Multiple Sclerosis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Assess the Effectiveness and Safety of Mayzent in Chinese Patients With Relapsing Forms of Multiple Sclerosis
- Status
- COMPLETED
- Phase
- N/A
177Lu-DOTATATE Modified Delivery Based on Individualized Dosimetry
- Status
- RECRUITING
- Phase
- PHASE2
Patient Characteristics, Treatment Patterns, and Healthcare Resource Utilization of Metastatic Melanoma Patients
- Status
- COMPLETED
- Phase
- N/A
177Lu-DOTATATE for Recurrent Meningioma
- Status
- RECRUITING
- Phase
- PHASE2
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
- Status
- RECRUITING
- Phase
- PHASE3
LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Non Interventional Study on Iron Toxicity After First Allo-transplant in MDS/CMML
- Status
- COMPLETED
- Phase
- N/A